Structure SARS-CoV-2

Creative Biolabs provides high-quality molecular diagnostic assay development services for SARS-CoV-2.

Creative Biolabs offers neutralizing antibody development services against CR3022 for SARS-CoV-2 infection.

Creative Biolabs offers high-quality BCX4430 (galidesivir) validation service for the treatment of SARS-CoV-2.

Creative Biolabs provides comprehensive antiviral drug and vaccine discovery services to help eradicate SARS-CoV-2.

Creative Biolabs provides animal model development service for the antiviral drug discovery to combat coronavirus infection.

Creative Biolabs provides adenosine analogue development services for the drug discovery of the new emerging SARS-CoV-2.

Creative Biostructure provides comprehensive preclinical research services for the development of recombinant subunit vaccines for coronavirus infection.

Creative Biostructure provides preclinical development services for recombinant vector vaccines to meet the urgent needs of SARS-CoV-2 vaccine R&D.

Creative Biostructure is accumulating preclinical research experience in nucleic acid vaccines, hoping to provide the optimal vaccine development services for different types of diseases caused by coronaviruses.

Creative Biostructure provides a wide range of contract research services involved in structure-based basic research, antiviral drug discovery, and vaccine development to help combat SARS-CoV-2 outbreak.

Creative Biostructure is equipped with advanced computational instruments and software to provide high-quality bioinformatics analysis services for genomic in-depth analysis and proteomic data interpretation of COVID-19.

Equipped with state-of-the-art optical microscopy, electron microscopy, and powerful data processing software, Creative Biostructure can provide visualization services for coronavirus-like particles based on a variety of technologies.

Creative Biostructure can offer a range of services for the structure determination of viral structural proteins/non-structural proteins, host proteins, antigen-antibody complexes, etc., using our three established structural biology technology platforms.

Backed by high-throughput screening and affinity ranking techniques and powerful equipment, Creative Biostructure can meet your needs for research on the protein interactions involved in coronavirus infections.

Anti-ACE2 (Rat) Monoclonal Antibody, Rabbit source.

Creative Biolabs provides animal model development service for the antiviral drug discovery to combat coronavirus infection.